Unmasking the Real Cost Drivers in U.S. Healthcare: A Critical Examination of Hospital Pricing and Policy Reform

  • CMPI | by: Peter Pitts and Jerry Rogers |
  • 06/23/2025 12:00 AM
READ THE FULL REPORT HERE

Abstract

This report critically examines the role of hospitals—particularly nonprofit institutions—in driving unsustainable healthcare costs in the United States. With hospital care consuming over $1.5 trillion in 2023 alone, the report explores structural inefficiencies, opaque pricing practices, fee-for-service incentives, and executive excesses that contribute to skyrocketing healthcare costs. Drawing on the analyses of both recent legislative debates and systemic trends, this paper merges policy critique with economic examination to argue for urgent and focused reform.

Introduction

Healthcare in the United States is in a crisis of affordability and accountability. In 2023, Americans spent more than $1.5 trillion at hospitals, accounting for nearly one-third of the nation’s total healthcare expenditures. While attention is often placed on pharmaceutical companies and insurance providers, hospital systems, especially nonprofit institutions, are the primary driver of healthcare cost inflation and systemic inefficiency.


 
Sign Up for Our Email Newsletter

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

DRUGWONKS BLOG